Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Valerion Therapeutics, LLC

Request full access

Valerion Therapeutics is a biotechnology company focused on developing targeted therapies for orphan genetic diseases - Valerion Valerion

Medford, United StatesBiotech & Life Sciences

About Valerion Therapeutics, LLC

Valerion Therapeutics is a biotechnology company that specializes in developing targeted therapies for orphan genetic diseases, which are rare conditions that affect a small percentage of the population. The company leverages a proprietary antibody-mediated delivery platform to direct therapies to specific tissues through a well-known and extensively studied transport pathway. This platform enhances the intracellular delivery of various therapeutic payloads, such as proteins, drugs, and oligonucleotides, by utilizing a transport mechanism prevalent in muscle and neurons and elevated in certain cancer types.

Valerion's unique approach involves the use of a novel antibody, 3E10, which has cell-penetrating properties dependent on the tissue-localized membrane transporter ENT2. This transporter is naturally enriched in critical organs like the heart and skeletal muscle, allowing Valerion to create targeted fusion and chemical conjugation products. These products offer new treatment options for diseases with limited or no current therapeutic solutions.

Founded in 2007 as 4s3 Bioscience by Dustin Armstrong, Ph.D., and Timothy Harris, Valerion has received early support through peer-reviewed, competitive funding and seed financing from Genzyme Ventures. The company underwent a name change in 2012 and secured a $20 million Series A financing round led by Alopexx, with Genzyme participating on a minority basis.

Valerion operates in the biotechnology sector, primarily serving patients with rare genetic disorders. The company's business model focuses on research and development, partnering with academic institutions and securing funding through grants and investments. Revenue is generated through the development and commercialization of its proprietary therapeutic products.

Source: Dealroom company data

Valerion Therapeutics, LLC in the Medford ecosystem

Live from Dealroom

The Valerion Therapeutics, LLC office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Valerion Therapeutics, LLC on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Valerion Therapeutics, LLC on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.